Shoulder Innovations is a biotechnology startup founded in 2015 and headquartered in the United States. Their pioneering invention, the InSet™ Glenoid, has become the cornerstone of the company's mission, as reflected in their slogan, "Shoulder Innovations began with the invention of the core technology – the InSet™ Glenoid." This innovative technology addresses the shortcomings of traditional fixation techniques in shoulder arthroplasty. The company's focus on improving procedure longevity and, ultimately, changing patients' lives is evident in their $45.00M Debt Financing investment from Trinity Capital on 22 August 2023. The simplicity and effectiveness of their design, developed from extensive experience, sets Shoulder Innovations apart in the Medical Devices and Health Care industries, reflecting their commitment to revolutionizing healthcare technology.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $45.00M | 1 | 22 Aug 2023 | |
Series D | $42.00M | 7 | 06 Mar 2023 | |
Venture Round | $21.60M | 8 | Alumni Ventures | 02 Nov 2020 |
Series A | $2.50M | 3 | 22 Oct 2018 | |
Series A | $1.60M | 3 | 07 Mar 2017 |
No recent news or press coverage available for Shoulder Innovations.